Oral administration of CDDO-Im, one of the most potent activators of Nrf2 in mouse liver known to date [83], prevented high-fat diet induced obesity and hepatic lipid accumulation in wild-type mice but not in Nrf2-null mice [19]. The gene discussed is NFE2L2; the disease is obesity due to melanocortin 4 receptor deficiency.